Updated clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb,administered in combination with pembrolizumab in patients with advanced solid tumors
C. Lebbe, et al. ESMO 2025 Abstract disponible sur le site de l’ESMO – Télécharger l’abstract – Télécharger le Poster